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LIST OF ABBREVATIONS 
ACR Albumin creatinine ratio 
PCR Protein creatinine ratio 
HBsAg Hepatatis B surface antigen 
HBeAg Hepatitis B ‘e’ (pre core) antigen 
HIV Human Immuno deficiency Virus 
Ab / Ag Antibody / Antigen 
RPR Rapid Plasma Reagin 
VDRL Veneral Disease Research Labaratory ( Test ) 
UPEP Urine Protein electrophoresis 
SPEP Serum protein electrophoresis 
ANA Anti nuclear Antigen 
Anti ds DNA Anti double stranded DNA antibody 
U1 RNP U1 – Ribonucleic protein 
NSAID Non steroidal anti inflammatory drugs 
DM Diabetes Mellitus 
FSGS Focal Segmental Glomerulosclerosis 
GFR / eGFR Glomerular Filteration Rate / estimated Glomerular filteration rate 
IHD / CAD Ischemic heart disease / coronary artery disease 
 
 
  
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
Urine analysis is an important tool in clinical medicine . Proteinuria is a 
condition in which urine contains an excess amount of proteins. 
. 
Proteinuria is 
sometimes the only evidence of severe kidney disease. Detection of proteinuria 
uncovers renal diseases and also frequently points to a specific diagnosis. Testing 
the urine for proteinuria has been part of the routine clinical examination. A 
positive urine protein dipstick test usually initiates the evaluation for proteinuria. 
Normal daily protein excretion in an adult does not exceed 150 mgs.[2] Persistent 
proteinuria of >1 gm/day, usually indicates renal disease. Proteinuria may be 
minimal (<1.0 gm/day), moderate (1–3 gm/day) and heavy (>3 gm/day).A 
proteinuria greater than 3.5 gm/1.7 m2 body surface area is called nephrotic range 
proteinuria.[2]  Important causes of minimal proteinuria are chronic pyelonephritis, 
diabetic nephropathy, interstitial nephritis and chronic renal failure. Moderate 
proteinuria is seen in nephritic syndrome and toxic nephropathies and heavy 
proteinuria indicates active glomerulonephritis. So quantification of protein is of 
utmost importance. A 24 hours urine protein estimation is a gold standard 
technique   for the quantitative estimation of proteinuria.  However it has few 
limitations. About 20% of the samples collected are rejected due to inadequate 
urine collection[1]. A urine PCR (Protein creatinine ratio) and a urine ACR 
(Albumin Creatinine ratio) have been found to be a good predictor of protein 
estimation over 24 hr urine collection in various studies. But a very few studies 
have compared urine ACR and urine  PCR together in patients with nephrotic 
range. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
OBJECTIVE 
 
 
 
 
 
 
 
 
 
 
OBJECTIVE 
1. To assess the relationship between 24 hours urine protein estimation and 
spot urine PCR (Protein Creatinine Ratio ) 
2. To assess the relationship between 24 hours urine protein estimation and 
spot urine ACR (Albumin Creatinine Ratio ) 
3. To assess which amongst the above mentioned(urine PCR and Urine ACR) 
is a better predictor of the 24 hours urine protein estimation 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
REVIEW OF 
LITERATURE  
 
  
REVIEW OF LITERATURE : 
 
Definition:  
Proteinuria is defined as urinary protein excretion of greater than 150 mg per 
day or greater than 140 mg / m2 of body surface area in children. 
 
Normal Physiology: 
The functional characteristics of the glomerular capillary filter have been 
extensively studied by the evaluation of the fractional clearance of molecules of 
different size , shape and charge.The normal glomerular endothelial cells forms a 
barrier and holds back cells and other particles. They are penetrated by large pores 
of 100 nm called ‘fenestrae’ that can easily be traversed by proteins. The 
glomerular basement traps most large proteins (>150Kda). Foot process of visceral 
epithelial cells (Podocytes) cover the urinary side of the glomerular basement 
membrane. They produce a series of narrow channels (Slit diaphragm) to allow 
passage of small solutes and water. These slit diaphragm bridges the slits between 
the foot process of the glomerular basement membrane . Negatively charged 
heparan sulfate proteoglycans cover the visceral epithelial cells[3]. This negative 
charge and size selectivity of glomerular basement membrane impedes the passage 
of anion molecules such as albumin, globulin and large molecular weight protein 
across the glomerular wall. The filtered smaller proteins are largely reabsorbed. 
This reabsorbtion takes place in the proximal tubule. Only small amount of the 
fltered load is excreted. There is also a shape restriction of molecules that allows 
elongated molecules to cross the glomerular capillary wall more readily than 
molecules of the same molecular weight. 
 Multiple factors have been proven to be important in the disruption of the 
glomerular capillary wall. These include tissue-degrading enzymes, complement 
components that assemble upon it, get deposited and oxygen radicals that target 
both the glomerular basement membrane and the slit diaphragm. Heparinase and 
hyaluronidase alterations in the amino glycan content of the glomerular capillary 
wall may play a role in increased protein excretion. Exciting clues to the specific 
components of the glomerular capillary wall, including mutations in the podocyte 
or proteins in the slit diaphragm, which result in proteinuria are coming in light due 
to studies based on molecular activity and genetics.[2] Impaired reabsorption of 
plasma proteins by proximal tubular epithelial cells is also another major 
mechanism resulting in proteinuria. A number of low-molecular-weight proteins, 
including β 1, β 2, and α1 microglobulins, are filtered by the glomerulus and 
absorbed by tubular epithelial cells. When tubular epithelial cells are damaged, 
these proteins are excreted. Based on the qualitative nature of proteinuria it is 
observed that excretion of high-molecular-weight proteins (e.g., fractional 
excretion of IgG) is indicative of glomerular damage. Similarly, tubular epithelial 
damage is more likely when there is excretion of low-molecular-weight proteins 
(e.g., fractional excretion of alpha1 microglobulin. This separation of high- from 
low-molecular-weight proteinuria has been suggested to be a predictor of clinical 
outcome in a number of glomerular diseases.A reaction that results in tubular 
atrophy and interstitial fibrosis has been found to occur as a consequence of the 
uptake of filtered proteins, including albumin by tubular cells.  
Classification of Proteinuria 
 
          Table 1 Classification of  Proteinuria [2] 
                                                    PROTEINURIA 
Benign Causes Pathological Causes 
1. Orthostatic /Postural 1. Glomerular 
2. Functional 2. Tubular 
3. Idiopathic / Intermittent 3. Overflow 
 
BENIGN PROTEINURIA : 
 It is usually a transient phenomenom. On repeated testing proteinuria 
disappears.  The renal function is normal and there is no significant pedal oedema 
and blood pressure alterations. The urine sediment is bland and the 24 hours 
collection is usually less than 1 gm. 
1) POSTURAL /ORTHOSTATIC PROTEINURIA  
The term “orthostatic proteinuria” is defined by the absence of proteinuria 
while the patient is in a recumbent posture and its appearance during upright 
posture, especially during ambulation or exercise. The total amount of protein 
excretion in a 24-hour period is generally less than 1.0 gram, but may be as much 
as 2 grams. Orthostatic proteinuria is uncommon in individuals over the age of 30. 
Orthostatic proteinuria is more common in adolescents. Two to five percent of 
adolescents have orthostatic proteinuria. It is diagnosed by split urine protein 
excretion examination.[4] In orthostatic proteinuria, the day time specimen 
typically has an increased concentration of protein, with night time specimen 
having a normal concentration usually less than 50 mg over eight hours. In true 
glomerular disease there is reduced protein excretion in the supine position but it 
will not return to normal as with orthostatic proteinuria. . Little convincing data 
exists on the usefulness of urinary protein-to-creatinine ratio measurements during 
recumbency versus ambulation as a diagnostic test for orthostatic proteinuria.  
Data on renal biopsies on orthostatic proteinuria are confusing. Some showed 
minor glomerular changes. Springberg et al.[5] found that long term prognosis of 
orthostatic proteinuria is benign in virtually all cases over many decades. An 
explaination given for postural proteinuria is that posture affects urinary protein 
excretion, probably via an increase in glomerular capillary hydrostatic pressure and 
change in permeability of the glomerular capillary walls. An alternate explanation 
given suggests  possible entrapment of renal veins as a cause of proteinuria.  
 
2). FUNCTIONAL PROTEINURIA 
It is seen during febrile illness, heavy physical exertion,emotional stress and  
cardiac failure. It is usually less than 0.5 gm/day but may be as heavy in few cases. 
It disappears with the resolution of causative disorder . Poortmans et al[6] 
 
and 
Kallmeyer et al[7] found that several gram of protein per liter of urine together 
with haematuria and even casts can be occasionally seen after exercise, especially 
jogging (jogger’s nephritis)[2]. Post exercise proteinuria is about 15 to 20 times the 
resting range of proteinuria. Resolution to normal range protein excretion may 
require about 4 hours . they also found that proteinuria was influenced mostly by 
the intensity of exercise rather than its duration.  
 
3) IDIOPATHIC PROTEINURIA  
This is seen in young healthy adults. This dipstick positive proteinuria 
disappears spontaneously by next clinical visit.  
PATHOLOGICAL PROTEINURIA 
1) GLOMERULAR PROTEINURIA  
A number of factors have proven to be important in the disruption of the 
glomerular capillary wall . These include tissue-degrading enzymes, immune 
complexes and complement components that assemble upon it, oxygen radicals 
that target both the glomerular basement membrane and the slit diaphragm, loss of 
the fixed anionic charge , disruption of the barrier, detachment of the epithelial 
podocytes. Heparinase and hyaluronidase alterations in the amino glycan content 
of the glomerular capillary wall may play a role in increased protein excretion. It is 
very common in clinical practice.Albumin is the major protein excreted in 
glomerular proteinuria and comprises of  85 – 90% of total protein excreted. Other 
proteins include relatively low molecular weight proteins like pre-albumin, 
orosomucoid, transferrin. McConnell et al on evaluation of proteinuria found that 
urinary excretion of more than 2 gm per 24 hours is usually a result of glomerular 
disease . 
 
  
Figure 1:Scanning electron microscopy of the glomerulus. T
of normal visceralepithelial cells (podocytes) is demonstrated. These cells and their processes cover the capillary, 
and ultrafiltration occurs betweethe fine branches of the cells.
 
Figure 2: Membranous Nephropathy: The capillary loops are thickened and there is expansion of the mesangial 
regions by the deposition of matrix. When a immunoflorescence is done it  shows granular subepithelial IgG along 
the basement membrane. 
 
he surface anatomy of the interdigitating foot processes 
 
 
Figure 3: Lupus nephritis DPGN. This image shows the diffuse endocapillary proliferative pattern of mesangial cells  
with infux of moncytes and granulocytes.  
 
Figure 4: Full house in SLE. This image shows florid  immune florescent deposition of IgG , IgM , IgA , C3 and 
C1q in the glomerulus –a pattern that is referred as ‘Full
 
 
 
-House’ seen especially in SLE Nephritis. 
Figure 5: IgA disease. This  light microscopy
regions and this process has affected the lob
Figure 6: Immumoflorescence microscopy image in IGA nephropathy :
with associated complement C3, and IgG or IgM, or both. IgG and IgM often are seen in le
than is IgA.  
 
 
 
 shows  widening with an increase in cellularity in the mesangial 
ules of some glomeruli to a greater degree than others.
 
 Granular mesangial deposits of IgA are seen 
sser degrees of intensity 
 
Table 2. Systemic Diseases that Cause Glomerular Injury and a 
Nephrotic Clinical Presentation[8] 
 
Disease state Common stiologies Laboratory findings 
 
Infections Hepatitis B (C less common) HBsAg, HBeAg 
  HIV HIV Ab 
  Syphilis RPR, VDRL 
Chronic 
diseases 
Diabetes ElevatedHbA1c, sugars 
  Amyloidosis UPEP/IEP  
  Sickle cell disease Hemoglobin 
electrophoresis 
  Obesity   
Malignancies Multiple myeloma SPEP, UPEP 
  Adenocarcinoma (lung, breast, colon most 
common) , Lymphoma 
 
Rheumatologic Systemic lupus erythematosus ANA, anti-dsDNA Ab 
  Rheumatoid arthritis Rheumatoid factor 
  Mixed connective tissue disease Anti-U1-RNP Ab 
Medications NSAIDs , Penicillamine, Captopril, Gold,etc.,   
 
(refer to page  for abbreviations used.) 
 
Common Glomerular injury patterns [4]:  
- Minimal change disease  
- Focal segmental glomerulonephritis  
- Idiopathic membranous glomerulonephritis  
- Membranoproliferative glomerulonephritis  
- IgA nephropathy  
 
2) TUBULAR PROTEINURIA  
Failure to reabsorb small-molecular-weight proteins is caused by damage to 
the renal tubulointerstitial region. This leads to tubular proteinuria. The most 
prevalent tubular protein (and the most abundant protein in normal urine) is 
Tamm-Horsfall protein, which enters the urine after synthesis in the tubular cells of 
the ascending limb of the loop of Henle and is secreted into the urine[3]. Under 
normal conditions, the small amount of urinary protein is composed of filtered 
proteins from plasma (50%) and proteins that are secreted into the urine from 
urinary tract cells (50%). Filtered proteins include small amounts of albumin 
(approximately 15% of the total urinary protein), immunoglobulins (5%), light 
chains (5%), β2-microglobulin (<0.2%), and other plasma proteins (25%).[2] 
Under conditions of tubulointerstitial injury, both filtered and secreted proteins are 
found in increased amounts in the urine, up to 1 to 2 g per day. Multiple 
mechanisms are responsible for tubular proteinuria. Injured tubules are unable to 
reabsorb the small-molecular-weight proteins normally filtered by the glomerulus, 
such as β2-microglobulin. Also as a result of tubular injury brush border 
components and cellular enzymes such as n-acetylglucosamine and lysozyme are 
secreted into the urine. Lastly, increased amounts of Tamm-Horsfall protein may 
be secreted into the urine by injured tubular cells of the ascending limb of the loop 
of Henle and the distal nephron.  
 Table 3. TUBULAR PROTEINURIA –  common causes[9]  
Hypertensive nephrosclerosis Acute hypersensitivity 
Polycystic Kidney disease Interstitial nephritis 
Pyelonephritis Oxalosis 
Obstruction Cystinosis 
Vesico – ureteric reflux Hypercalcemia 
Fanconi syndrome Hyperuricemia 
Heavy metals Sickle cell disease 
Uric acid nephropathy Drugs (NSAID, Antibiotics) 
 
3) OVERFLOW PROTEINURIA  
It is due to filtration by normal glomerulus of an abnormally large amount of 
low molecular weight proteins, which exceeds the capacity of the normal tubules 
for reabsorption. It is characterized by the presence of abnormal peak or spike on 
urinary electrophoresis. Most often, this is a result of the immunoglobulin over 
production that occurs in multiple myeloma. The resultant light change 
immunoglobulin fragments (Bence Jones proteins) produce a monoclonal spike in 
the urine electrophresis.  
OVERFLOW PROTEINURIA –CAUSES [9] 
-Multiple myeloma  
-Myoglobinuria  
-Rhabdomyolysis  
-Lymphoproliferative disorders  
 
 
SELECTIVITY OF  PROTEINURIA : 
The type of protein excreted gives a clue to the likely origin of the 
proteinuria and the likely pathology. The type of protein excreted can be 
ascertained by various  methods like urine protein electrophoresis , immune 
electrophoresis . In glomerular proteinuria, a urine protein electrophoresis (UPEP) 
demonstrates primarily albumin rather than globulins, whereas tubular proteinuria 
demonstrates a predominance of small-molecular-weight proteins. (Immune electro 
phoresis) IEP can quantify this distinction further if a definitive spike is not present 
on UPEP. A urinary albumin to β2 microglobulin ratio of 10 to 1 is indicative of 
tubular proteinuria, in contrast to glomerular proteinuria, in which this ratio usually 
exceeds 1000:1. In comparison, in normal urine, the albumin to β2 microglobulin 
ratio ranges from 50:1  to  200:1. Evaluation of overflow proteinuria may be aided 
by UPEP, which separates urinary proteins into five peaks based on the molecular 
weights of the proteins. The five peaks include albumin and α1, α 2, β 2, and gamma 
globulins. For example, an abnormal peak or spike  occurring in the gamma region 
suggests the presence of a monoclonal gammopathy. A selectivity index is 
calculated by the ratio of IgG clearance to the albumin clearance[13].  If the 
selectivity index is lesser then 0.1 , then the proteinuria is highly selective and if it 
is greater than 0.2 then its non selective. 
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According to Tay et. al[12] another formula can also be used for the calculation of 
selectivity index of proteinuria. 
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A ratio of <0.16 indicates highly selective proteinuria. In children, minimal 
change nephropathy causes selective proteinuria, whereas non-selective proteinuria 
raises the possibility of an alternative type of renal disease and might lead to a 
recommendation of renal biopsy to avoid steroid treatment when this would be 
unlikely to be of benefit. Measurement of selectivity in adults is of very limited 
use. 
MICROALBUMINURIA : 
Microalbuminuria is defined as 30 to 300 mg/d in a 24-h collection or 30 to 
300 microgm/mg creatinine in a spot collection (preferred method). The 
appearance of microalbuminuria (incipient nephropathy) in DM is an important 
predictor of progression to overt proteinuria (greater 300 mg/d) or overt 
nephropathy and is an independent risk factor for cardiovascular morbidity. 
Besides diabetes mellitus, a number of other conditions have been found to be 
associated with microalbuminuria, including female gender, old age, etc. (Jones et 
al. 2002)[18]. 
Albuminuria was also found in high blood pressure patients (Rosa and 
Palatini 2000)[14].Accordingly Pannacciulli et al. 2001[15], found that obesity and 
hyper-triglyceridaemia as well as smoking (Gambaro et al. 2001)[16] was 
associated with albuminuria. Oral contraceptive use and hormone replacement 
therapy (Monster et al. 2001)[17] has been shown to increase albuminuria.  
METHODS OF DETECTING AND MEASURING PROTEINURIA  
A) DETECTION OF PROTEINURIA  
1.  Dipstick analysis  
2.  Precipitation methods  
B) QUANTIFICATION OF PROTEINURIA  
1. Turbidimetric method  
2. Biuret method  
3. Dye binding technique  
C) CHARECTERIZATION OF PROTEINURIA  
1. Immune electrophoresis  
2. Column gel chromatography  
3. Agarose gel / Polyacrylamide gel electrophoresis  
 
1) DIPSTICK ANALYSIS  
It is used in most out-patient settings to detect proteinuria. It semi 
quantitatively measures the urine protein concentration. Paper strip is impregnated 
with indicator dye like bromocresol green. It changes colour in presence of protein. 
In the absence of protein the dipstick panel is yellow. With increasing 
concentrations of protein in urine the dye indicators undergo sequential colour 
changes from pale green to green and blue. The binding of a protein to the 
indicators, which are structurally similar to bromocresol green, is highly pH 
dependent. Albumin binds to indicators at pH between 5 and 7. Other proteins bind 
at lower pH, but with a lower affinity than albumin, while Bence Jones protein 
does not bind at any pH. Hence , it preferentially detects negatively charged 
urinary proteins like albumin. However albumin levels between 30-300mg/dl are 
not detected. Light chains and some low molecular weight protein are not detected 
by stick tests. The sticks are buffered to keep the pH constant. Leaving the sticks in 
the urine will wash out the buffer and give a false reading. They should be read 
immediately. Sticks are very sensitive giving a trace or positive reading with many 
normal urine samples containing only about 100 mg/l of protein The results are 
expressed on a scale from 0 to +++ or ++++, at each of which correspond 
approximate protein concentrations, which vary according to the manufacturer. 
 
FALSE POSITIVE DIPSTICK PROTEINURIA  
- (alkaline urine) urine pH > 7  
- Highly concentrated urine  
 - deeply pigmented urine 
 - quaternary ammonium compounds  
- phenazopyridine 
- Gross Haematuria  
- Dipstick immersed too long  
- Presence of Penicillin, Sulfonamide or Tolbutamide.  
- Pus  
- Semen /vaginal secretions  
 
FALSE NEGATIVE DIPSTICK PROTEINURIA 
- Dilute urine (specific gravity > 1.015)  
- When the urinary proteins are non albumin 
Especially in case on the low molecular weight proteins.  
 - Bence Jones proteins 
 
 
 
 
 
 
 
 
QUANTITATIVE ANALYSIS OF PROTEINURIA 
Table 4. Tests for Quantitative detection of Proteinuria [2] 
TEST 
Analytical 
sensitivity 
(mg/l) 
Linearity (mg/l)  
 
Distinctive features 
Turbidimetric 
 
   
Sulfosalicylic acid   
 
10-20 10-3000 
Albumin overestimation; some 
glycoproteins are not detected; 
Trichloroacetic   
 
20 20-2400 
Same sensitivity for albumin and 
globulins;many drugs can interfere; 
Benzethonium 
chloride 
   
 
10 10-1600 
Albumin over-estimation; under-
estimation of increased protein 
concentrations;less turbidity for 
gamma globulins than for albumin; 
Dye binding    
Coomassie brilliant 
blue 
  
 
2.5 5-1500 
High sensitivity; underestimation of 
tubular proteins; interference from 
various metabolites, drugs. 
Poncea   
 
20 100-1600 
Same sensitivity for albumin and 
globulins; positive interference 
with aminoglycoside antibiotics; 
Biuret(Precipitation)    
 
Tsuchiya reagent 
 
5-2000 
( volume  – 2ml) 
very few interferences reference 
method recommended by the 
American Association for 
Clinical Chemistry 
Folin-Lowry reagent 10 10-700 
 
Interference by tyrosine 
 QUALITATIVE ANALYSIS 
 
Several methods are available for the qualitative analysis of proteinuria. 
Electrophoresis Electrophoresis on cellulose acetate or agarose after protein 
concentration or using very sensitive staining (silver or gold stains) is one of the 
most widely used method. Better resolution is obtained by sodium dodecylsulfate-
polyacrylamide gel electrophoresis (SDS-PAGE), which detects urinary proteins 
on the basis of their molecular weight. This technique allows the identification of 
proteins of tubular origin with low molecular weight (e.g. 10 kDa) 
 
SAMPLE COLLECTION: 
 
The method of collecting a urine sample is of critical importance especially 
when the specimen is to be examined microscopically. As suggested by (Kouri et 
al. 2000)[19]. It is preferable to give written instructions describing the procedure 
to the patient to avoid errors in sample collection. These should include avoiding 
strenuous physical exercise (e.g. marathon, jogging) in the hours before the 
collection period. This is because such activities may lead to physiologic 
proteinuria and/or haematuria. Collection during menstruation is alsoavoided as 
there is a risk of contamination with blood. Depending on the clinical diagnosis 
and suspicion, a timed urine collection can be requested. For e.g. 24 hr collection , 
overnight collection or a spot urine collection may be needed.  
A 24 hr urine collection involves starting the collection time in morning by 
emptying the bladder and discarding the first morning urine, then collecting all 
urine for the subsequent 24 hours, including the first morning void the following 
day. The urine should be preferably refrigerated during the entrie collection period. 
This is not possible in many situations and so an alternative method is advocated  
by adding one cup of vinegar to the collection container to act as a preservative.  
  In case, a spot sample is requested at least 50 ml of urine should be 
collected. Urine should be collected in a container supplied by the laboratory. It 
should have a capacity of at least 50-100 ml and a diameter opening of at least 5 
cm to allow easy collection by both females and males (Kouri et al. 2000)[19]. 
 
 
STORAGE OF SPECIMENS : 
 
Analysis within one hour of voiding is done to avoid alterations in physical 
or chemical features. Several means of preservation, such as addition of thymol, 
borate or toluene or refrigeration at 4°C have been proposed. Some of these can, 
however, cause some interfering chemical reactions. For e.g. formalin may in some 
cases precipitate protein and thymol does interfere with the acid precipitation test 
for proteins. Thus, there is no ideal preservative yet and hence the study of fresh 
urine is always advised. 
 
ADEQUACY OF SAMPLE COLLECTION : 
 
To ensure adequate collection, a 24-hour total creatinine excretion should be 
obtained on the same sample. In females under steady-state conditions of renal 
function, the 24-hour urinary excretion of creatinine should equal approximately 
15 to 20 mg per kg of ideal body weight; in males, the excretion should be 18 to 25 
mg per kg of ideal body weight. Creatinine is produced at constant rate and in an 
amount directly proportional to skeletal muscle mass. With steady state day-to-day 
renal function, each gram of Creatinine in 24 hour urine collection represents 18.5 
gms of fat free skeletal muscle[20].
. 
Since concentration of Creatinine remains 
relatively constant on a daily basis, in patients with a steady state of renal function, 
it can be used to assess the adequacy of timed urine collections.  
 
 
 Figure 1: APPROACH TO A PATIENT WITH PROTEINURIA [21] 
 
 
 
  
 
 
 
 
 
 
 
 
METHODOLOGY 
 
 
 
 
 
 
 
 
 
 
  
METHODOLOGY: 
Source of Data: 
A total of 72 patients attending the department of Internal Medicine and 
department of Nephrology of Government Stanley Medical College, Chennai , on 
both out-patient basis and in-patient basis were included in this study. 
Duration of Study : 1 year ( July 2010 – June 2011) 
INCLUSION CRITERIA  
1) Age < 80 years 
2) Patients with proteinuria > 3.5 gms /24 hours 
3) Patients on immunosuppressive therapy for Glomerulo-nephritis 
4) Patients of either sex 
5) Patients not dependent on Hemo-dialysis 
  
EXCLUSION CRITERIA  
1) Patients of age less than 14 years  
2) Gross Haematuria  
3) Patients with febrile illness  
4) Inadequate sample collection (An inadequate urine sample was defined as 
calculated 24 hours urine creatinine excretion out of range to the expected 
total 24 hours urine creatinine(15-20mg/ideal body weight for females and 
18-25 mg/kg ideal body weight for males) 
5) Heart Failure 
6) Patients on Anti-Proteinuric drugs (Eg: ACE inhibitors ,Angiotensin receptor 
Blockers,   sulphonamides )  
7) Head Injury 
8) Intense physical exertion  
9) Dehydration 
10) Patients with urine output less than 400 ml per 24 hours. 
 
METHOD OF DATA COLLECTION: 
All patients attending the General Medicine and Nephrology Out Patient / In 
Patient Department and having significant proteinuria were asked to collect 24 
hours urine protein. Instructions were given to the patient. Then they were asked to 
void the first morning sample and then collect urine from that day onwards till the 
next day including the morning first void sample. Urine was collected in a 5 litre 
sterile plastic can with a 25 ml of acetic acid or 5-10 ml of conc. Hydrochloric 
acid, added as preservative. The collected sample was analysed for 24 urine protein 
estimation using the turbidimetry method using sulfosalicyclic acid. 
Patients who had a 24 hours urine protein excretion more than  3.5 gm and 
satisfying the mentioned inclusion and exclusion criteria were identified. They 
were given an informed consent form and only after the receipt of their signatures/ 
thumb print on the informed consent form, they were enrolled into the study. Blood 
samples were also collected and sent for analysis. Patients were also requested to 
collect their first void sample the next morning and this sample was analysed for 
urine PCR and urine ACR. The PCR was calculated using the following formula: 
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The ACR was calculated using the following formula: 
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Then again the same day a 24 hours urine protein sample was collected as per the 
above mentioned method. 
GFR was calculated based on Cockcroft-Gault equation. 
Estimated creatinine clearance (mL/min) = [(140 – age) × body weight( kg)] / 
       [72 × serum Creatinine (mg/dL)] 
The product was multiplied by 0.85 if the patient is female. 
The patients were divided into groups depending on their eGFR. 
1). Patients with eGFR > 30 ml /min 
2). Patients with eGFR < 30 ml/min 
3). Patients with GFR < 15ml/min. 
The correlation coefficient (r) was computed using the following formula:[78] 
   r = Correl(x,y) where ‘x’ and ‘y’ are  the variables and x- any y- are their 
respective mean values. 
 
The same formula was used for calculation of coefficient of correlation 
- for the entire sample population ( 24 hours urine protein and PCR) 
-- for the entire sample population ( 24 hours urine protein and ACR) 
- then separately for Group A and B  
- for patients with Stage 5 CKD 
- for the entire sample population ( 24 hours urine protein and PCR) in logarithmic. 
Finally the strength of correlation was compared. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
RESULTS 
 
 
 
 
 
 
 
 
  
RESULTS: 
This study included 72 patients, who had 24 hours urine protein of  >3.5 
gms/day with varying degree of renal dysfunction. The patients were segregated 
into groups based on their estimated creatinine clearance rate and the data was 
tabulated and analysed. 
 
Age Distribution in study population : 
Table 5. Age Distribution 
Age Group No. of patients Percentage 
14 – 30 years 27 38 
31 – 60 years 37 51 
61 years and above 8 11 
 
In this study , the age of patient ranged from 14 to 78 years. The incidence of 
nephrotic range proteinuria was maximum around 31 to 60 years(51%). 
 
 
Table 7: Age Distribution 
Age distribution 
of patients 
 Years 
Range 14 – 78 
Mean  37.89 
Median 35 
 
Table 7: Sex distribution in the study population : 
Sex of the patients No. of patients 
Male 40 
Female 32 
 
In this study there were 40 men ( 56%) and 32women(44%).  
 
 
 
 
 
 
  
Medical Illness in Patients with Nephrotic  range proteinuria 
Table No. 8. Co-morbid Medical Illness in Patients with Nephrotic  range 
Proteinuria 
Risk Factor No. of patients Percentage 
Hypertension 44 61 
DM 0 0 
SLE 7 10 
Hepatitis B 3 4 
Hepatitis C 1 1 
HIV 1 1 
NSAID use 27 38 
Family History 0 0 
Drugs / Native 
medicines 7 10 
IHD / CAD 0 0 
Hypothyroidism 4 6 
None 15 21 
 
Because few patients had multiple risk factors the total of percentage coloumn will 
not be 100. 
Accordingly , it was found that there is a maximum incidence of 
Hypertension in patients with nephrotic range proteinuria (61%). In this study, the 
patients having Diabetes mellitus were not included as almost all of them were on 
Tab. Enalapril which acts as a anti-protenuric drug and hence may act as a 
confounding factor. NSAID use was present in 38% patients and it was prevalent 
in age group >30 years.  There were total of 7 patients(10%) who were suffering 
from lupus nephritis. There were 21% patients who did not harbor any of the 
mentioned risk factors and co-morbid illness.  
Etiology based on Biopsy Results: 
Table 9. Etiology based on Biopsy Results: 
HISTOLOGICAL DIAGNOSIS No. Of Patients Percentage (%) 
Chronic Glomerular Sclerosis 6 8.33 
 Diffuse Proliferative Glomerulonephritis 9 12.5 
 Focal Segmental Glomerulosclerosis 11 15.3 
 IgA Nephropathy 16 22.2 
 Membranous  Nephropathy 14 19.4 
 Membrano Proliferative Glomerulopathy 4 5.56 
 Myeloma Kidney 2 2.78 
 Cresentic Glomerulo-sclerosis 4 5.56 
 Biopsy Not Done 6 8.33 
 
This table shows the histopathological diagnosis of the patients included in 
study. Accordingly,it was observed that the most common cause of nephrotic range 
proteinuria was Ig A Nephropathy followed by Membranous Glomerulo -
Nephropathy. Biopsy was not done in  6 patients. It was interesting to note that 2 
patients finally were diagnosed as Myeloma.  
The three main renal biopsy diagnosis for patients with nephrotic range 
proteinuria are IgA nephropathy , Membranous Nephropathy and FSGS. A 
comparison between the 3 groups was done. 
Table 5 : Nephrotic  Syndrome Characterstics : 
Renal Biopsy 
Diagnosis 
Mean Age 
(years) 
Male: 
Female 
Ratio 
Urine 
PCR(mean) 
24 hours urine 
Protein(mean) 
Ig A Nephropathy 32.1 9:7 5.67 5.7 
Membranous 
Nephropathy 34.7 1:1 8.93 9.38 
FSGS 36.6 8:3 4.97 5.74 
 
According to this table, all the three important causes for nephrotic range 
proteinuria  had a mean age around 32-36 years. There was a male preponderance 
in Ig A nephropathy and FSGS . However the ratio was 1:1 in Membranous 
nephropathy. The mean 24 hours urine protein and urine PCR was higher in 
membranous nephropathy as compared to both FSGS and Ig A nephropathy.  
In this study, a total of 7 patients had SLE who had a nephrotic flare. All of 
them were females with a mean age of 26.1years. The mean 24 hours urine protein 
and Urine PCR were 6.37  and 6.59 respectively. The renal biopsy of these patients 
showed Membranous nephropathy in 4 patients ( 57%) and DPGN in 2 patients 
(29%). Biopsy was not done in 2 patients.  
Classification of patients based on CKD stage 
Table 6. Classification of patients based on CKD stage 
CKD Stage eGFR  (in 
ml/min ) 
No. of male 
patients 
No. of Female 
patients 
Total No. of 
patients 
I >90 11 1 12 
II 60-89 14 8 22 
III 30-59 9 8 17 
IV 15-29 4 13 17 
V <15 2 2 4 
 
In this study Stage II CKD occupied the maximum no. of patients - 22 (30%) 
followed by stage III CKD -17 patients (24%). About 30 % of patients had eGFR 
below 30 ml/min and this included a total of 4 patients (5%) with stage V CKD. 
About 47% of patients were having a eGFR 60ml/min and above.  
 
Statistical Analysis : 
Table 7:Paired Samples Statistics ( 24 hours urine protein and Urine PCR ) 
 Mean Number 
Standard 
Deviation 
Standard  
Error 
Mean 
Significance 
‘p’ value 
24 Hours Urine 
Protein 6.5739 72 2.1333 0.2514 <0.001 
Urine PCR 5.3986 72 2.0198 0.238  
 
 
Table 8. Paired Samples Correlations ( 24 hours urine protein and Urine PCR ) 
 
 Number Co-efficient of correlation ( r ) 
24 Hours Urine Protein and urine 
PCR 72 0.825 
 
According to this scatter plot , the relationship between 24 hours urine 
protein and urine PCR is linear ( R2  = 0.561). the graph also shows that urine PCR 
is almost numerically equal to 24 hours urine protein upto excretion rate of 5 
gm/24 hr. however the relationship weakens as the proteinuria increases . 
In this study the equation obtained for the calculation of 24 hours urine protein is 
as follows: 
24 hours urine protein = 0.653(urine PCR)  +  2.459  
Table 9. Paired Samples Statistics ( 24 hours urine protein and Urine ACR ) 
  Mean Number Standard Deviation 
Standard Error of  
Mean 
 Urine ACR 4.4684 72 1.82494 .21507 
24 Hours Urine 
Protein 6.5739 72 2.13329 .25141 
 
Table 10. Paired Samples Correlations ( 24 hours urine protein and Urine ACR ) 
 Number Co-efficient of correlation ( r ) 
24 Hours Urine Protein and urine 
ACR 72 0.636 
 
This is a scatter plot where in the 24 hours urine protein has been plotted against 
urine ACR of each patient .According to this graph there is a linear regression (R2 
= 0.396) . there is considerable variation from the linearity and it widens as we 
move to right half of the scatter plot. According to this study 
24 hours urine protein = 0.729(urine ACR) + 3.309  (R2 = 0.396) or  
24 hours urine protein = 3.136[(urine ACR)1/2 ] +  0.068  (R2 = 0.381)( using  
mathematical transformation ) 
 
 LOGARITHMIC RELATIONSHIP: 
In this study , when a scatter plot of log (24 hours urine protein)  and log 
(urine PCR) was plot the relationship obtained had a coefficient of correlation( r) 
of   0.776 . The equation obtained  
Log (24 hours urine protein ) = 0.948(log urine PCR) + 0.027   ( with R2 = 0.6). 
 
COEFFIECIENT OF CORRELATION: 
 
Table 13. Distance Matrix between urine ACR , PCR and 24 hrs urine protein. 
Distance Matrix 
 Euclidean Distance 
 ACR PCR 24 Hours Urine Protein 
ACR .000 21.561 22.984 
PCR 21.561 .000 14.008 
24 Hours Urine Protein 22.984 14.008 .000 
This is a dissimilarity matrix   
  
According to this table, it clearly shows that when a distance matrix is used to 
compare the   coefficient of correlation between urine PCR and urine ACR with 24 
hours urine protein each , urine PCR ( Eucliedean distance 14.008)   is more 
closely associated to 24 hours protein than  urine ACR( Eucliedean distance 
22.984)   
 
Table 11. Comparison of coefficient of correlation(  urine PCR and 24 hours 
urine protein) 
Group (CKD Stage) No. of Patients Correlation ( r value) p value 
1 to 3 51 (71%) 0.805 0 
4 and 5 21 (29%) 0.724 0 
5 alone 4 (5%) 0.682 0 
 
This table shows that as the GFR reduces or as the CKD stage worsens the co-
efficient of correlation becomes weaker. It is maximum in patients with GFR > 30 
ml/min. (CKD stage 1,2,3) (r = 0.805). however it is weakest at stage 5 CKD 
disease( r = 0.682). 
 
  
Table 14: Distance Matrix between urine PCR and 24 hrs urine protein at different 
stages of CKD. 
Distance Matrix 
  Euclidean Distance  
 PCR  CKD 
(1to 3) 
24 Hrs Urine 
Protein CKD 
(1to3) 
PCR  CKD 
(4 and 5) 
24 Hrs Urine 
Protein CKD ( 
4 and 5) 
PCR 
CKD 5 
24 Hrs Urine 
Protein CKD 
5 
PCR  CKD (1to 3) .000 2.025 6.273 6.064 7.632 5.629 
24 Hrs Urine Protein 
CKD (1to3) 
2.025 .000 5.980 5.714 6.777 4.762 
PCR  CKD (4 and 5) 6.273 5.980 .000 3.518 8.619 8.466 
24 Hrs Urine Protein 
CKD ( 4 and 5) 
6.064 5.714 3.518 .000 8.099 8.782 
PCR CKD 5 7.632 6.777 8.619 8.099 .000 4.086 
24 Hrs Urine Protein 
CKD 5 
5.629 4.762 8.466 8.782 4.086 .000 
This is a dissimilarity matrix      
 
According to this table, we plot a distance matrix of urine PCR and 24 hours 
urine protein at different stages of CKD. This table shows that the Euclidean 
distance increases as the CKD stage worsens. It is 2.025 in patients with GFR > 
30ml/min (CKD stage 1,2 or 3) ,3.518 in patients with  GFR < 30 ml/min( CKD 
stage 4 and 5) and it is 4.086 ( maximum ) with  GFR < 15ml/min (CKD stage 5). 
Table 12. Comparison of coefficient of correlation 
Parameters compared Co-efficient of co-relation ( r ) 
Urine PCR and 24 hours urine protein 0.825 
Logarithmic correlation between urine PCR and 24 hours 
urine protein 0.776 
Urine ACR and 24 hours urine protein 0.636 
Urine PCR and 24 hours urine protein ( in patients with  GFR 
> 30 ml/min ) 0.805 
Urine PCR and 24 hours urine protein ( in patients with  GFR 
< 30 ml/min ) 0.724 
Urine PCR and 24 hours urine protein ( in patients with  GFR 
< 15 ml/min 0.682 
Urine ACR and 24 hours urine protein( in patients with  GFR 
>30 ml/min ) 0.672 
Urine ACR and 24 hours urine protein( in patients with  GFR 
< 30 ml/min ) 0.503 
 
This table shows that the co-efficient of correlation is maximm with 24 hours urine 
protein and urine PCR. 
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DISCUSSION 
 
 
 
 
 
 
 DISCUSSION : 
24 hours urine protein excretion estimation is gold standard for quatitative 
assessment of proteinuria. This approach, however, is considered by many to be 
unfeasible in some circumstances, particularly in the outpatient setting, because of 
the difficulty associated with obtaining a complete collection. Mitchell et al. [22] in 
their study on the elderly age patients concluded by saying that they had to discard 
more than 20% of the samples because they were considered to be incomplete. 
Similarly Chitalia et al.[1] in their study had to dispose off upto 10% of the 
samples collected for akin reasons. In this study for a total of 72 patients, a total of 
83 sample had to be collected as 11 samples (13.3%) had to be discarded.  
 It is well known fact that there is tremendous intra-day variation in the 
concentration of urinary protein. The estimates fluctuate by upto 500%. This is the 
biggest disadvantage of use of a random urine samples or short collection period 
protein concentration measurements.[23] This variation is thought to be attributable 
to several factors, including (a) diet, (b) exercise, (c) rate of diuresis, (d) 
recumbency, and (e) variation in water intake and excretion . The variation may be 
further exacerbated by pathologic changes in blood pressure and renal 
architecture.[23] These reasons hence , call for a 24 hours urine collection. 
Urine PCR  has been suggested as an alternative to 24 hr urine collection. To 
calculate this ratio first morning urine sample is collected and sent for analysis. 
The protein and creatinine concentration are detected and then the ratio is obtained. 
It is expressed in terms of mg of protein per mg of creatinine. This calculation of 
protein-creatinine ratio on spot urine samples corrects for variations in urinary 
concentration due to hydration. Newman et al.[59] found that the mean 
intraindividual variation in the Urine PCR ratio was 38.6%, whereas that of the 
protein excretion was 96.5%.  Koopman et al. [24] had made a similar observation. 
Based on these observations it is recommended by American Guidelines (K/DOQI 
clinical practice guidelines for chronic kidney diseases: evaluation, classification 
and stratification 2002) that the protein-creatinine ratio should preferably be 
calculated on the first morning urine specimen[2].  
 According to Deeks et al [25], although several statistical techniques are 
available, the way that the data are presented are not always readily interpretable 
by the practicing clinician. However, the most important factor is to have a clear 
definition of the way in which the test is to be used. He insists on the use of Urine 
PCR as a screening tool to rule out significant proteinuria. This view has also been 
shared by Price et al.(2005) [23]. 
One of the major aspect highlighted by Price et al was the fact that the study 
population used for conducting such comparative studies that a high prevalence of 
proteinuria. Hence the results obtained from such a population could not be 
extended to the general population as the prevalence of proteinuria in the general 
population is quite low. Hence the positive predictive value of such a test falls 
rapidly in such situations.  
Craig et al.[26], and Boulware et al. [27],Leeman et. al [63]  in a cost-
effectiveness analysis, suggested that screening for proteinuria would be useful 
only in high-risk populations, e.g., older people and persons with hypertension and 
that Urine PCR might be a reliable indicator of significant proteinuria.   
 Urine PCR can very well be an alternative to the 24-h collection (Ginsberg 
et al. 1983).In the experience of Ginsberg et al. (1983)[28] the measurements 
obtained with this method correlated well with those obtained in the classical way. 
In fact, all patients with proteinuria of greater than 3.5 g/24 h had a ratio of greater 
than 3.5 in single voided samples, and all patients with a proteinuria of less than 
0.2 g/24 h had a ratio of less than 0.2. it can thus be concluded that the urine PCR 
is numerically equal to the 24 hours urine protein estimation. 
However in this study the urine PCR ranged from 2.7 to 12.44.  All the 
patients except for 1, (98.6%) had a Urine PCR more than 3.1 and 64 (89%) 
patients had a urine PCR more than 3.5   
According to Schwab et al. (1987)[29], patients (representing a broad 
spectrum of renal diseases, a wide range of proteinuria, and various degrees of 
reduction in glomerular filtration rate) had Protein-to-creatinine ratios in single-
voided urine samples in well correlation with measurements of 24-hour urinary 
protein. This simple single-voided test is reliable and useful in the screening, 
assessment, and follow-up of proteinuria and avoids the problems associated with 
24-hour urine collection.  
Ruggenenti et al. 1998[60] in their study on non-diabetic patients have come 
a conclusion that urine PCR and 24 hours urine protein estimation correlate very 
well almost the entire range of glomerular  filteration rate and stages of chronic 
kidney disease. 
Zelmanowitz et al[31] reported that proteinuria measurement in a random 
urine sample was a reliable and a simple method for screening and diagnosing 
overt diabetic nephropathy. 
Price et al.[23] in their systemic meta-analysis from 16 studies investigating 
urine PCR for quantitative proteinuria assessment in several settings 
(preeclampsia, renal disease) concluded that the following ranges: sensitivity (69- 
96%)  and specificities ( 41 - 97%), positive predictive value (46 - 95%) and 
negative predictive values (45 - 98%), positive likelihood  ratios (1.8 and 16.5) and 
negative likelihood ratios (0.06 and 0.35). 
In this study the patients under stage 4 and 5 CKD , had correlation co-
efficient (r) values 0.72. However in patients with stage 5 CKD had correlation co-
efficient (r) values 0.682. This is less as compared to the correlation coefficient 
obtained in patients with eGFR > 30 ml/min(0.805) and entire study group as a 
whole (0.825). 
There are few studies that have highlightened this aspect of use of urine PCR 
in estimation of 24 hours urine protein estimation.[32,33,34,35] 
Siwach et al [32]
 
found that in patient with normal or mild to moderately 
impaired renal function the product of PCR and estimated daily urinary creatinine 
excretion positively correlated well with the estimated 24 hours urine protein ( r = 
0.88 and 0.99), but poorly correlated in patients with advanced renal failure ( r = 
0.56)  
Mohan et al [34]
 
studied the correlation between the expected 24 hours urine 
protein calculated from spot urine protein – Creatinine ratio and the estimated 24 
hours urine protein in type 2 Diabetes. The positive correction was good, but was 
less with increasing degree of proteinuria. 
Sharma et al [35] studied the correlation between the Protein-Creatinine 
ratio in spot urine sample with 24hours urine protein with varying degree of renal 
dysfunction and concluded a good positive correlation in patients with advanced 
renal failure. Correlation co efficient (r) values were 0.889, 0.788, 0.595 in patients 
with serum Creatinine < 1.5 mg/dl, 1.5-4 mg/dl, > 4 mg/dl respectively 
Goldman et. al [33], Morales et. al(2004)[68] found that the possible reason 
for poor correlation is these patients is that with progression of renal failure the 
urinary Creatinine excretion falls especially after serum Creatinine exceeds 6 
mg/dl. 
 Many studies have concluded that urine PCR is numerically equal to the 24 
hours urine protein excretion. However the studies also conclude that this relation 
gets weaker as the GFR worsens and heavy proteinuria. Ruggenenti et al. 
(1998)[60]  suggested that the logarithmic values of 24 hours urine protein and 
Urine PCR co-relate  equally well and maintain the relationship even in heavy 
proteinuric patients. 
 In this study, a scatter plot of  log 24 hours urine protein and log urine PCR 
showed that there is excellent correlation between the two variables and the values 
are numerically almost equal. This is a further proof  to say that  urine PCR can be 
reliably used as an estimate of 24 hours urine protein even in patients with 
nephrotic range proteinuria. 
 
 
 
Table 13. Comparison between various studies 
 
Name of the Study 
 
Comparison 
between 24 hours 
urine protein and 
… 
No. of 
Patients 
 
r value 
 
p value 
 
Quadri et al., 1994 [43] Urine PCR 75 0.92 <0.0001 
Young et al., 1996 [44] Urine PCR 45 0.8 <0.001 
Robert et al., 1997 [45] Urine PCR 71 0.94 <0.001 
Saudan et al., 1997 [46] Urine PCR 100 0.93 <0.001 
Ramos et al., 1999 [47] Urine PCR 47 0.94 Not stated 
Evans et al., 2000 [48] Urine PCR 51 0.95 <0.0001 
Rodriguez-Thompson et 
al., 2001 [49] 
Urine PCR 138 0.8 <0.001 
Durnwald and Mercer, 
2003 [50] 
Urine PCR 220 0.64 <0.0001 
Al et al., 2004 [51] Urine PCR 185 0.56 <0.01 
Yamasmit et al., 2004 [52] Urine PCR 42 0.95 <0.001 
Combs et al., 1991 [53] Urine PCR 329 0.98 <0.0001 
Ginsberg et al., 1983 [28] Urine PCR 46 0.97 Not stated 
Schwab et al., 1987 [29] Urine PCR 101 0.96 Not stated 
Abitbol et al., 1990 [54] Urine PCR 64 0.95 <0.001 
Dyson et al., 1992 [55] Urine PCR 148 0.77 <0.001 
Steinhauslin et al., 1995 
[56] 
Urine PCR 318 0.93 <0.001 
Chitalia et al., 2001 [1] Urine PCR 170 0.97 Not stated 
Torng et al., 2001 [57] Urine PCR 289 0.79 <0.0001 
Ralston et.al.,1988 [58] Urine PCR 102 0.92 <0.001 
Mitchell.et.al.,1993[10] Urine PCR 52 0.98 <0.0001 
Morales et. al 2004 [68] Urine PCR 43 0.91 <0.001 
Xin et. al 2004[69] Urine PCR 72 0.823 <0.001 
Rodby et. al [67] Urine PCR 33 0.90 Not stated 
Boler et. al[73] Urine PCR 54 0.9936 <0.001 
 
In this table it is very clear that there is a definite excellent correlation 
between 24 hours urine protein and urine PCR and this is true over a wide range of 
proteinuria and varying renal function. The studies included in the above table 
have a majority population of pregnant women wherin urine PCR was done to rule 
out significant proteinuria which is associated with pre-eclamsia. However it also 
includes 2 studies done on post renal transplant patient and patients attendin 
nephrology out patient departments each.In our study there were similar results. 
  
Urine Albumin- creatinine ratio  
Similar to calculation of urine PCR , urine ACR can also be calculated for 
spot first morning urine samples. The urine albumin-creatinine ratio on random 
urine samples can be used  (Assadi et. al 2002)[36]in diabetic patients to assess the 
grade of nephropathy. With this method microalbuminuria is defined as a ratio of 
30-300 µg albumin/mg creatinine.[74]  
Urinary albumin concentration correlates well with urinary total protein and 
also with 24 hour urinary protein over a very wide range of the level of proteinuria. 
It was hence being investigated as a marker of 24 hours urine protein.[75]  
Newman et al[59] concluded that albumin concentrations increased 
significantly after vigorous activity and there is considerable diurnal variation . 
The increase was almost eliminated when the albumin result was divided by the 
creatinine concentration suggesting that a decreased urine flow and not increased 
glomerular permeability causes an increase of post-exercise albuminuria.First 
morning sample was collected to further reduce this diurnal variation.   
 Though this test is especially useful in diabetic patients , it can also be used 
to assess pathological proteinuria in non diabetic patients. According to Price 
2005,[23] considerable disparity in the measurement of total protein in urine is 
most probably is a result of differences in the analytical specificities of the methods 
used  as well as changes in the calibration methods. This may have contributed to 
the variation in the diagnostic performance among the studies. It has been 
suggested that the measurement of albumin might offer a means of reducing 
methodologic variation. It also has the potential for increasing the clinical 
diagnostic sensitivity. 
The most common methods to measure micro albuminuria are 
radioimmunoassay (Woo et al. 1978)[62], enzyme immunoassay (Fielding et al. 
1987)[37], nephelometric (Stamp 1988)[38], and immune-turbidimetric (Shukla et 
al. 1988)[39]. In this study quantitative estimation of albumin was done using 
immune-turbidimetric method. These detect can  albumin at concentration of 10-20 
mg/l, and have a 70-90 per cent specificity.[40,41,42] 
Only few studies exist for use of urine ACR as an estimate for 24 hours 
urine protein excretion.Guy M et. al [61] conclude urine ACR accurately predicted 
an abnormal 24 h urine albumin. He also concluded that urine ACR  can be used in  
predicting proteinuria by careful choice of cut-offs in patients with kidney disease 
to rule in or rule out abnormal 24 h losses of protein and albumin. Early morning 
urine sample as well as random samples can be used as surrogates for 24 hours 
urine protein excretion. However , this study primarily concentrated its efforts on 
use to urine ACR to rule out significant albuminuria. 
In this study there was no significant difference between 24 hours urine 
protein excretion and urine ACR. There also was an excellent correlation between 
24 hours urine protein excretion and urine ACR(r = 0.636). However the 
correlation is weaker as compared to that with urine PCR(r = 0.825).  the strength 
of relationship as calculated using a scatter plot was good but not as good enough 
as that seen with urine PCR and 24 hours urine protein. As  the correlation is 
considerable weaker the correlation between 24 hours urine protein excretion and 
urine ACR in patients with reducing renal function would be expectedly lower. 
Accordingly the values suggested the same. The co-efficient of correlation between 
urine ACR and 24 hours urine protein was 0.672 and 0.503 in patients with GFR > 
30ml/min and GFR < 30ml/min respectively. Hence it can be concluded that urine 
PCR is a better index for estimation of 24 hours urine protein excretion as 
compared to urine ACR.  
 Further prospective studies will be required in specific patient populations to 
validate these conclusions.Wilson et. al [76] and Kim et. al[77] have also 
highlighted the use of protein-osmolality ratio as a reliable marker to esaimate 2 
hours urine proein excretion. However there are very few studies to confirm this.  
Comparison with the Indian Scenario of Nephrotic Syndrome: 
S Siddappa and associates[79] in a recently published data on 400 renal 
biopsy at a centre in Hyderabad, South India show the recent increasing trend of 
increasedincidence of IgA disease and conclude that IgA nephropathy is the most 
common cause of primary glomerular disease. the most common presentation of 
IgA was a nephrotic range proteinuria followed by chronic renal failure. Almost all 
patients with IgA disease had atleast one episode of documented microscopic (>5 
RBC/ Hpf) or macroscopic hematuria. The mean proteinuria of the IgA group 
ranged from 3.54 – 5.56 in the common subtypes of IgA nephropathy.The mean 
age was 36.6 years and male preponderance was seen. They also concluded that 
there is undue genetic susceptibility of the Asian population to both the 
development of IgA disease and its complications. 
  U. Das and colloegues [80] in another recently concluded Indian study, a 
collective experience of renal biopsy results over 19 years at a single centre was 
analysed. They conclude that nephrotic syndrome remains the most common 
indication for a renal biopsy( 49% ). The most frequent cause of Nephrotic 
syndrome in the patients above 20years of age was Minimal Change Disease 
followed by Membranous nephropathy and then FSGS. Authors said that there was 
change in policy for renal biopsy and immunoflorescence staining over the years 
and probably a selection bias which may have confounded the results partially. 
They also concluded that for Membranous Nephropathy the mean age was 40, sex 
ratio 2.3:1 and a mean proteinuria of 4.8 gm/day. Similarly for IgA disease the 
mean age was 26 , sex ratio 3.3:1 and a mean proteinuria was 2gm/day.  In FSGS 
group the mean age was 25, sex ratio 2.25:1 and a mean proteinuria was 3.3 
gm/day. In this study they have also highlighted to the fact that among all the IgA 
nephropathy patients 44.6% presented with nephrotic range proteinuria.   
According to Reshi AR et al [81], who recently published their data over 
nephrotic syndrome in single centre in Kashmir,North India , the most common 
cause of nephrotic syndrome in adults was minimal change disease followed by 
FSGS , MN and IgA nephropathy. This study points to the regional variation in the 
etiology in India itself.  
The largest data from a single centre in India came from Vellore,South India 
where the last 30 years(1986-2002) with analysis of 5415 native kidney biopsy 
results[82]. Nephrotic syndrome was the most common indication (65%) and 
among the entire group the most common cause was Mesangio-proliferative 
glomerulonephritis, The prevalence of  FSGS was 17%. IgA nephropathy 
prevalence was 8.6%.Minimal Change disease and membranous nephropathy 
prevalence was  11.6 and 9.7 .%  respectively. 
In our study however the most common of adult onset non diabetic nephrotic 
range proteinuric patients was IgA nephropathy(22%) followed by membranous 
nephropathy(19%) and then FSGS(15%). 
 
Drawbacks of this study: 
Some authors have stressed upon the fact that the mere performance of a regression 
analysis and then calculating a high correlation coefficient ( r ) may not always 
enable a physician to make a reliable decision of substituting 24 hours urine 
collection with a urine PCR [1]. Thus, the high degree of association assessed by 
high coefficient of correlation values (almost approaching 1 )between the Urine 
PCR ratio and the 24-h protein excretion does not necessarily give dependable 
information on whether use of the ratio in a random sample will enable clinicians 
to reduce their dependence on the 24-h urine collection. There is no follow up and 
sequential PCR and 24 Hours urine protein comparison .The sensitivity urine PCR  
to accurately detect proteinuria in nephrotic range was not calculated. There is a 
possibility of variation in results if a different method was used for the quantitative 
estimation of proteinuria. Cost benefit analysis was not done.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
 
 
 
 
 
 
 
 
 
 
  
CONCLUSIONS : 
1.PCR in the first morning urine sample is found to be an useful index for 
quantification of proteinuria in patients with heavy proteinuria and varying degrees 
of  renal dysfunction.  
2.There was good positive correlation between spot urine PCR and 24 hours 
estimated protein.  
3.The correlation was maximum in patients with  GFR > 30ml/min. 
4.The positive correlation was least in patients severe renal dysfunction (Stage 5 
CKD).  
5.There was no significant difference between expected and estimated 24 hours 
urine protein. 
6.Urine PCR is easy to perform, inexpensive and less time consuming method for 
measuring of proteinuria. It can thus be used in the out patient setting for screening 
and quantification of proteinuria. 
7.  Urine ACR in the first morning urine sample is found to be an useful index for 
quantification of proteinuria in patients with heavy proteinuria and varying degrees 
of  renal dysfunction. 
8. There was good positive correlation between spot urine Albumin-Creatinine 
ratio and 24 hours estimated protein.  
9. Urine PCR correlates better than urine ACR in quantitative estimation of 24 
hours urine protein estimation 
10. Log Urine PCR is almost equivalent to Log of 24 hours urinary protein. 
  
  
 
 
 
 
 
 
 
 
 
 
 
SUMMARY 
 
  
SUMMARY: 
24 hours urine protein estimation has been standard to quantify proteinuria. 
However it is cumbersome, may have to collection errors, required good patient 
compliance, and result in delay in diagnosis. A meta-analysis showed that urine 
PCR is an useful index to estimate 24 hours urine protein excretion .This study was 
undertaken to find if the urine PCR from first morning urine sample could reflect 
the amount of protein in 24 hours in patients with nephrotic range proteinuria. 72 
patients with proven nephrotic range proteinuria and varying degree Creatinine 
clearance were investigated. An excellent correlation was found between 24 hours 
urine protein and protein- Creatinine ratio. However correlation weaken as the 
GFR  worsens and is weakest in patients with stage 5 CKD. The correlation 
between urine ACR and 24 hours urine protein is considerably weaker than that 
with urine PCR. This study supports the use of a single voided Protein-Creatinine 
ratio to predict 24 hours urine protein. Use of urine PCR avoids collection errors, 
less time consuming and is suitable for out patient departments. 
ABSTRACT: 
Background and Objective : 
Quantitation of proteinuria by 24-hour urine collection is a conerstone of 
monitoring disease activity in patients with patients with nephrotic range 
proteinuria(>3.5 gms/day). Such collections, however, are often inaccurate, 
inadequate, tedious, time consuming. Up to 20 % of 24 hours urine collection 
samples get discarded because of inadequate or incorrect collection.[1] The urine 
PCR (protein creatinine ratio) and urine ACR (albumin creatinine ratio) corrects 
for variations in urinary protein concentration due to hydration and is not affected 
by a decrease in urine output in patients with renal insufficiency. It is far more 
convenient than timed urine collections. There are several studies showing the 
correlation in sub-nephrotic range proteinuric patients. But there are comparatively 
fewer studies correlating these variables in the only nephrotic range. Also very few 
studies have compared the efficacy of urine PCR with urine ACR to quantify 24 
hours proteinuria. 
Method : 
72 patients  with  proven nephrotic range proteinuria with varying degree of renal 
dysfunction were included in this study. First morning spot urine sample was 
collected  for the estimation of urine PCR and urine ACR. Then the values were 
compared. 
Results : 
There is significant correlation not only between 24 hours urine protein and 
protein-Creatinine ratio ( r = 0.825) ( P < 0.001) but also between 24 hours urine 
protein and albumin -Creatinine ratio ( r = 0.636) ( P < 0.001). The correlation 
between urine PCR and 24 hours urine protein becomes weaker as the Glomerular 
Filtration Rate (GFR) worsens and is weakest at stage 5 chronic kidney 
disease(CKD) (r = 0.682).The logarithm value  of 24 hours urine protein is 
numerically equal to logarithm value of urine PCR(r=0.876)   
Conclusion: 
Spot morning urine samples for urine PCR and urine ACR( though less precise ) 
are  precise indicators of proteinuria and represents a simple, rapid procedure in 
establishing severity of heavy proteinuria. 
Key Words : 
Proteinuria , urine protein - creatinine ratio, urine albumin - creatinine ratio, 
quantitative estimation 
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PROFORMA 
Name : 
Age / Sex :       Marital Status : 
Educational Status :     Occupation : 
Address : 
 
Clinical features:- 
Facial puffiness 
Generalised Edema 
 Urine frequency 
Dysuria 
Burning Micturation 
Altered sensorium 
Loss of consciousness 
Pleural Effusion 
Ascitis 
Fever 
 
Past History:- 
SLE………………………………………………(duration…………….;treatment………………) 
Diabetes Mellitus……………………….( duration……………treatment………………..) 
Hypertension…………………………….( duration ……….;treatment………………….) 
IHD……………………………………........(duration………………..;treatment……………) 
Stroke………………………………………(duration………………..;treatment……………) 
Renal disease 
Other Autoimmune Disease 
Liver disease 
Thyroid dysfunction 
 
Other Significant Past History : 
 
Personal History: 
Diet   - vegetarian / non-vegetarian /mixed / fruits / fast food 
Apetite -good /poor 
Bowel  - normal / constipation / loose stools 
Bladder - normal / polyuria / oliguria 
Sleep  - normal / reduced  
Mental Stress- low / mod / high 
Smoking - smoker 
Ex- smoker - quit since …………. 
Never a smoker   
Alcohol: - duration 
  -unit 
Tobacco  - 
Exercise - 
 
 
Treatment History : 
 
 
Family History:  ( Y / N ) 
Coronary Artery Disease 
Diabetes 
Renal Disease 
Hypertension 
 
General Physical Examination: 
Anthropometric measurements : 
Ht ( in cm ) - 
Wt ( in kgs ) - 
BMI ( kg /m2 ) 
TBSA 
 
Pallor 
Icterus  
Cyanosis 
Clubbing 
Lymphadenopathy 
Pedal oedema 
 
Vitals: 
Temperature ( in F ) 
Pulse  ( /min) 
BP ( mm of Hg ) 
Pulse pressure ( mm of Hg ) 
Respiratory Rate 
  
Systemic Examination : 
CVS : 
RS: 
PA: 
CNS: 
 
ECG 
 
X ray chest : 
 
 
 
 
 
  
 
 
 
 
 
Renal Biopsy : 
 
 
 
 
Hb  
TC  
DC  
ESR  
Platelet  
Urine  
Protein  
Sugar  
Cells  
Casts  
Urea  
Creatinine  
S. Sodium  
S. Potassium  
S. Calcium:  
S. Phosphorus:  
Serology  
HIV  
HBsAg  
Anti- HCV  
Urine Analysis: 
24 hours urine protein estimation  
No. of attempts  
Urine Creatinine concentration  
Spot urine Protein – Creatinine Ratio  
Spot urine Albumin – Creatinine Ratio  
Spot urine Protein – Osmolality Ratio  
CONSENT  FORM( English ) 
 
 
1). I agree to participate in the study entitled  ‘CORRELATION BETWEEN THE 
SPOT URINE PROTEIN CREATININE RATIO, SPOT URINE ALBUMIN 
CREATININE RATIO AND 24 HOURS URINE PROTEIN ESTIMATION IN 
PATIENTS WITH NEPHROTIC RANGE PROTEINURIA’  
 
2).I confirm that I have been told about this study in my mother tongue and have 
had the opportunity to ask questions  
 
3). I understand that my participation is voluntary and I may refuse to participate at 
any time without giving any reasons and without affecting my benefits. 
 
4). I agree not to restrict the use of any data or results that arise from this study. 
 
Name of the participant : 
 
Sign / Thumb print : 
 
Sign of the Investigator 
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Sex 
Wt 
Ht 
risk 
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PCR  
24Hrs U 
Pr 
Biopsy 
report 
dipstic 
attmpt 
1 
Sa
ri
ba
ba
nu
 
52
 
F 
82
 
16
2 
ht
n,
ns
ai
d 
29
 
2.
2 
11
2 
36
.4
4 
4 
21
00
 
4.
36
 
0.
58
 
3.
71
 
4.
51
 
FS
G
S 
3 
1 
2 
Ja
am
al
 
19
 
M
 
42
 
16
6 
ht
n 
14
6 
8.
3 
11
5 
8.
50
4 
5 
65
0 
5.
78
 
1.
82
 
9.
87
 
7.
45
 
Ig
A
 
N
ep
hr
op
at
hy
 
3 
1 
3 
R
am
ch
an
dr
an
 
75
 
M
 
57
 
16
9 
ht
n,
ns
ai
d 
66
 
2 
12
5 
25
.7
3 
3 
13
50
 
8.
16
2 
1.
1 
9.
66
 
14
.3
5 
M
em
br
an
ou
s 
3 
1 
4 
V
el
m
ur
ga
n 
39
 
M
 
59
 
16
2 
dr
ug
 
23
 
0.
8 
97
 
10
3.
5 
1 
15
50
 
2.
43
7 
1.
01
 
2.
7 
4.
23
 
FS
G
S 
 
3 
1 
5 
V
is
hv
al
in
ga
m
 
33
 
M
 
58
 
17
1 
  
33
 
1.
5 
11
3 
57
.4
6 
2 
11
00
 
4.
37
 
1.
5 
4.
17
 
6.
89
 
Ig
A
 
N
ep
hr
op
at
hy
 
3 
1 
6 
V
ija
yl
ak
sh
m
i 
22
 
F 
42
 
16
8 
ht
n,
sl
e 
10
7 
4.
4 
75
 
12
.5
2 
4 
31
00
 
4.
57
 
0.
43
 
7.
13
 
4.
66
 
D
PG
N
 
3 
1 
7 
R
aj
a 
31
 
M
 
62
 
16
8 
ht
n 
12
1 
8.
2 
98
 
11
.4
5 
5 
11
50
 
6.
31
 
1.
24
 
7.
23
 
10
.3
2 
M
em
br
an
ou
s 
3 
1 
8 
M
ah
al
ak
sh
m
i 
15
 
F 
39
 
15
2 
  
19
 
0.
9 
11
0 
60
.1
9 
2 
16
50
 
2.
56
 
0.
6 
5.
19
 
4.
91
 
FS
G
S 
 
3 
1 
9 
M
ar
ia
m
m
a 
54
 
F 
72
 
16
2 
ns
ai
d 
33
 
1.
3 
97
 
52
.9
2 
3 
17
00
 
6.
84
 
0.
69
 
5.
82
 
6.
83
 
D
PG
N
 
3 
1 
10
 
Sa
si
ku
m
ar
 
20
 
M
 
57
 
16
2 
ht
n 
36
 
1.
7 
78
 
55
.8
8 
2 
11
50
 
4.
72
 
1.
09
 
7.
36
 
9.
23
 
M
em
br
an
ou
s 
3 
1 
11
 
K
ri
sh
na
n 
45
 
M
 
53
 
16
6 
ht
n,
ns
ai
d 
48
 
1.
2 
99
 
58
.2
8 
2 
17
50
 
3.
75
 
0.
86
 
4.
66
 
6.
8 
Ig
A
 
N
ep
hr
op
at
hy
 
3 
2 
12
 
D
un
iy
ar
an
i 
23
 
F 
43
 
16
5 
ht
n,
sl
e 
98
 
4.
5 
11
0 
12
.4
2 
4 
15
50
 
3.
62
 
0.
79
 
6.
41
 
7.
82
 
M
em
br
an
ou
s 
3 
1 
13
 
Sa
si
ku
m
ar
 
20
 
M
 
58
 
16
2 
  
16
 
0.
9 
92
 
10
7.
4 
1 
17
50
 
2.
97
2 
0.
62
 
8.
11
 
8.
81
 
M
em
br
an
ou
s 
3 
2 
14
 
K
es
av
an
 
40
 
M
 
59
 
16
6 
ht
n 
56
 
2.
4 
12
3 
34
.1
4 
3 
21
50
 
3.
14
 
0.
56
 
4.
59
 
5.
53
 
FS
G
S 
3 
1 
15
 
L
ak
sh
m
i 
27
 
F 
49
 
15
6 
ht
n,
hy
po
th
ro
id
 
28
 
0.
9 
78
 
68
.3
6 
2 
21
00
 
2.
26
4 
0.
45
 
5.
71
 
5.
4 
FS
G
S 
3 
1 
16
 
Sa
th
ya
m
ee
na
 
32
 
F 
51
 
16
0 
ht
n 
62
 
2.
6 
10
1 
23
.5
4 
4 
17
00
 
7.
34
 
0.
64
 
10
.5
 
8.
54
 
Ig
A
 
N
ep
hr
op
at
hy
 
3 
2 
17
 
V
el
m
ur
ga
n 
38
 
M
 
61
 
16
1 
dr
ug
 
28
 
1.
2 
10
4 
72
.0
1 
2 
95
0 
2.
31
 
1.
51
 
6.
21
 
8.
9 
C
G
N
 
3 
1 
18
 
Sh
aj
ah
n 
39
 
M
 
48
 
16
6 
ht
n 
11
2 
3.
4 
11
2 
19
.8
 
4 
21
50
 
3.
27
 
0.
72
 
5.
08
 
7.
86
 
FS
G
S 
3 
1 
19
 
K
ri
sh
na
n 
78
 
M
 
65
 
17
2 
ht
n,
ns
ai
d 
17
 
0.
9 
10
6 
62
.1
9 
2 
27
00
 
2.
74
 
0.
5 
3.
77
 
4.
91
 
no
t d
on
e 
3 
1 
20
 
R
aa
ga
ia
h 
35
 
M
 
63
 
17
7 
hi
v 
18
 
0.
9 
80
 
10
2.
1 
1 
12
50
 
3.
22
 
1.
51
 
5.
77
 
6.
83
 
FS
G
S 
3 
1 
21
 
V
ija
yk
um
ar
 
42
 
M
 
79
 
16
8 
ht
n,
ns
ai
d 
17
 
0.
9 
11
5 
11
9.
5 
1 
15
50
 
2.
64
 
1.
03
 
4.
37
 
4.
75
 
Ig
A
 
N
ep
hr
op
at
hy
 
3 
2 
22
 
T
ha
ng
ad
ur
ai
 
34
 
M
 
67
 
17
4 
  
22
 
0.
9 
11
9 
10
9.
6 
1 
15
50
 
4.
67
 
1.
21
 
3.
22
 
5.
87
 
C
G
N
 
3 
1 
23
 
K
au
sa
ly
a 
70
 
F 
51
 
15
5 
ht
n,
hb
v,
ns
ai
d 
29
 
1.
2 
85
 
33
.0
6 
3 
23
00
 
2.
71
9 
0.
4 
6.
1 
5.
62
 
M
PG
N
 
3 
2 
24
 
Fa
rx
an
a 
25
 
F 
45
 
15
8 
  
17
 
0.
9 
11
7 
63
.8
9 
2 
21
50
 
3.
21
 
0.
44
 
7.
6 
7.
23
 
M
PG
N
 
3 
2 
25
 
Se
nb
eg
um
 
26
 
F 
47
 
16
7 
ht
n,
sl
e 
69
 
4.
9 
11
2 
12
.1
5 
4 
23
50
 
3.
92
 
0.
52
 
7.
32
 
9.
36
 
M
em
br
an
ou
s 
3 
1 
26
 
L
ak
sh
m
i 
60
 
F 
62
 
15
3 
ht
n,
hy
po
th
yr
oi
d,
ns
ai
d 
73
 
1.
7 
93
 
32
.4
2 
4 
17
50
 
2.
76
 
0.
6 
4.
6 
4.
83
 
D
PG
N
 
3 
1 
27
 
Sr
ila
ks
hm
i 
35
 
F 
72
 
16
7 
  
87
 
4.
5 
87
 
18
.6
7 
4 
75
0 
3.
95
 
1.
74
 
4.
07
 
5.
32
 
Ig
A
 
N
ep
hr
op
at
hy
 
3 
1 
28
 
Fa
th
im
ab
ee
vi
 
74
 
F 
62
 
16
2 
ns
ai
d,
dr
ug
 
21
 
1.
1 
16
0 
41
.3
3 
3 
22
00
 
3.
26
 
0.
42
 
5.
99
 
5.
54
 
M
ye
lo
m
a 
1 
1 
29
 
Ja
m
un
a 
26
 
F 
53
 
16
6 
ht
n 
39
 
1.
7 
10
7 
39
.4
9 
3 
11
00
 
8.
92
 
1.
12
 
10
.7
 
8.
34
 
Ig
A
 
N
ep
hr
op
at
hy
 
3 
1 
30
 
M
an
ik
an
da
n 
39
 
M
 
60
 
15
8 
ht
n 
51
 
1.
9 
11
0 
44
.3
 
3 
65
0 
3.
31
9 
1.
99
 
4.
97
 
5.
84
 
Ig
A
 
N
ep
hr
op
at
hy
 
3 
1 
31
 
V
is
hv
an
at
ha
n 
35
 
M
 
66
 
17
5 
  
25
 
0.
8 
11
3 
12
0.
3 
1 
24
50
 
2.
57
 
0.
58
 
3.
61
 
3.
72
 
Ig
A
 
N
ep
hr
op
at
hy
 
3 
1 
32
 
B
ha
gy
ar
aj
an
 
35
 
M
 
60
 
17
7 
ht
n,
dr
ug
 
24
 
0.
8 
93
 
10
9.
4 
1 
12
50
 
8.
89
 
1.
44
 
12
.3
 
10
.3
 
M
em
br
an
ou
s 
3 
1 
33
 
D
ev
ik
a 
 
32
 
F 
51
 
15
6 
ht
n,
sl
e 
11
0 
5.
2 
96
 
11
.7
7 
5 
18
00
 
2.
06
 
0.
6 
3.
45
 
3.
73
 
no
t d
on
e 
3 
2 
34
 
Su
sa
im
ar
y 
32
 
F 
67
 
16
4 
  
32
 
1.
3 
94
 
61
.8
5 
3 
11
50
 
7.
52
 
0.
92
 
10
 
9.
72
 
D
PG
N
 
3 
1 
35
 
D
ill
i B
ab
u 
16
 
M
 
48
 
16
7 
ht
n 
98
 
4.
5 
11
5 
18
.3
7 
4 
65
0 
2.
46
 
2 
5.
06
 
4.
08
 
FS
G
S 
3 
1 
36
 
Se
et
al
ak
sh
m
i 
51
 
F 
64
 
16
1 
ns
ai
d 
23
 
1 
11
4 
63
.2
9 
2 
23
50
 
8.
52
 
0.
44
 
10
 
9.
81
 
M
em
br
an
ou
s 
3 
1 
37
 
A
bh
ir
am
i 
31
 
F 
50
 
16
8 
ht
n,
sl
e 
61
 
3.
1 
87
 
19
.5
3 
4 
65
0 
5.
78
 
1.
68
 
9.
21
 
7.
13
 
M
em
br
an
ou
s 
3 
1 
38
 
Sa
ng
ee
ta
 
14
 
F 
38
 
15
4 
  
28
 
0.
9 
97
 
59
.1
1 
2 
17
00
 
2.
69
1 
0.
62
 
3.
9 
3.
78
 
M
PG
N
 
3 
1 
39
 
Su
nd
ar
i 
58
 
F 
67
 
16
5 
ht
n,
ns
ai
d 
56
 
2.
5 
11
2 
24
.4
2 
4 
95
0 
7.
53
 
1.
37
 
10
.3
 
9.
56
 
M
em
br
an
ou
s 
3 
1 
40
 
Se
lv
i 
21
 
F 
55
 
15
9 
ht
n 
54
 
1.
3 
16
0 
55
.9
4 
2 
12
50
 
7.
41
 
0.
79
 
8.
9 
8.
86
 
M
em
br
an
ou
s 
3 
2 
41
 
M
ar
ia
gr
ac
y 
29
 
F 
48
 
16
3 
hy
po
th
yr
oi
d 
35
 
1.
2 
91
 
49
.3
3 
2 
27
00
 
3.
62
 
0.
42
 
4.
68
 
5.
31
 
Ig
A
 
N
ep
hr
op
at
hy
 
3 
1 
42
 
Ja
ya
pr
ak
as
am
 
28
 
M
 
49
 
17
1 
  
42
 
0.
8 
10
3 
95
.2
8 
1 
12
50
 
4.
89
 
1.
1 
11
.3
 
9.
95
 
M
em
br
an
ou
s 
3 
1 
43
 
Jo
hn
 B
as
ha
 
55
 
M
 
73
 
16
1 
hc
v,
ns
ai
d 
21
 
0.
9 
92
 
95
.7
6 
2 
13
00
 
4.
33
 
1.
02
 
6.
9 
8.
13
 
D
PG
N
 
3 
1 
44
 
Se
lv
i 
25
 
F 
45
 
15
5 
ht
n 
69
 
2.
4 
73
 
23
.9
6 
4 
75
0 
3.
41
6 
1.
04
 
8.
73
 
6.
81
 
Ig
A
 
N
ep
hr
op
at
hy
 
3 
1 
45
 
Sa
ng
ee
ta
 
14
 
F 
41
 
15
6 
  
24
 
1.
2 
90
 
47
.8
3 
2 
95
0 
6.
11
 
0.
74
 
9.
85
 
6.
93
 
M
PG
N
 
3 
1 
46
 
M
oh
an
 
51
 
M
 
59
 
16
3 
ht
n,
ns
ai
d 
23
 
0.
9 
82
 
81
.0
3 
2 
16
50
 
4.
35
 
0.
69
 
5.
37
 
6.
12
 
FS
G
S 
3 
1 
47
 
A
ru
nk
um
ar
 
36
 
M
 
71
 
15
9 
  
29
 
1.
2 
87
 
85
.4
6 
2 
22
00
 
3.
48
 
0.
63
 
3.
34
 
4.
63
 
R
PG
N
 
3 
1 
48
 
M
an
ik
an
da
n 
42
 
M
 
77
 
16
9 
ht
n,
ns
ai
d 
47
 
1.
7 
11
4 
61
.6
5 
3 
24
00
 
6.
26
 
0.
59
 
5.
74
 
6.
72
 
FS
G
S 
3 
1 
49
 
Se
nt
hi
lk
um
ar
 
42
 
M
 
76
 
15
9 
ht
n,
ns
ai
d 
33
 
2.
5 
17
4 
41
.3
8 
3 
16
50
 
7.
36
 
0.
64
 
10
.2
 
9.
15
 
M
em
br
an
ou
s 
3 
1 
50
 
Sa
th
ya
m
oo
rt
hy
 
47
 
M
 
71
 
17
5 
ht
n,
ns
ai
d 
43
 
2.
4 
79
 
38
.2
1 
3 
12
50
 
4.
24
 
1.
18
 
5.
77
 
7.
02
 
FS
G
S 
3 
1 
     5
1 
K
al
ai
va
ni
 
48
 
F 
62
 
16
1 
ns
ai
d 
59
 
2.
9 
73
 
21
.8
5 
4 
13
50
 
4.
64
 
0.
86
 
3.
55
 
4.
13
 
Ig
A
 
N
ep
hr
op
at
hy
 
3 
1 
52
 
Su
bb
ur
aj
an
 
22
 
M
 
44
 
17
1 
  
44
 
1.
7 
13
4 
42
.4
2 
2 
13
50
 
6.
57
 
1.
11
 
4.
55
 
6.
88
 
D
PG
N
 
3 
1 
53
 
M
an
oh
ar
an
 
47
 
M
 
72
 
15
9 
ht
n,
ns
ai
d 
66
 
2.
1 
91
 
44
.2
9 
3 
21
50
 
2.
54
 
0.
68
 
3.
99
 
5.
66
 
no
t d
on
e 
3 
1 
54
 
Jo
se
ph
 
67
 
M
 
59
 
17
4 
ht
n,
ns
ai
d 
41
 
1.
6 
11
4 
37
.3
9 
3 
14
50
 
4.
23
 
0.
99
 
4.
97
 
6.
75
 
no
t d
on
e 
3 
1 
55
 
Se
ka
r 
56
 
M
 
57
 
17
2 
ht
n,
ns
ai
d 
41
 
1.
2 
11
6 
55
.4
2 
2 
21
00
 
5.
21
 
0.
68
 
7.
52
 
5.
74
 
C
G
N
 
3 
2 
56
 
ch
an
dr
as
he
kh
ar
 
55
 
M
 
61
 
16
0 
hb
v,
ns
ai
d 
24
 
0.
8 
69
 
90
.0
2 
2 
25
00
 
2.
77
4 
0.
46
 
3.
14
 
3.
62
 
M
ye
lo
m
a 
1 
1 
57
 
K
av
ith
a 
67
 
F 
65
 
15
4 
ht
n,
hy
po
th
ro
id
,d
ru
g 
24
 
0.
9 
94
 
58
.5
8 
3 
14
00
 
4.
15
 
0.
75
 
6.
47
 
5.
65
 
R
PG
N
 
3 
1 
58
 
M
d.
 A
li 
48
 
M
 
69
 
17
6 
ht
n,
ns
ai
d 
52
 
2.
2 
14
4 
40
.0
8 
3 
14
50
 
4.
77
 
1.
21
 
7.
45
 
6.
75
 
C
G
N
 
3 
1 
59
 
Po
on
go
di
 
17
 
F 
47
 
16
2 
ht
n 
46
 
2 
97
 
32
.1
2 
3 
11
50
 
2.
88
 
1.
01
 
3.
24
 
3.
77
 
Ig
A
 
N
ep
hr
op
at
hy
 
3 
1 
60
 
K
an
na
n 
15
 
M
 
42
 
15
1 
ht
n 
42
 
2.
7 
84
 
27
.0
1 
3 
55
0 
7.
47
 
2.
18
 
4.
55
 
5.
41
 
Ig
A
 
N
ep
hr
op
at
hy
 
3 
1 
61
 
H
ar
i 
30
 
M
 
64
 
16
6 
ht
n 
11
2 
4.
5 
12
0 
21
.7
3 
4 
24
50
 
2.
34
 
0.
49
 
6.
89
 
8.
43
 
no
t d
on
e 
3 
2 
62
 
A
ru
ls
el
vi
 
24
 
F 
49
 
15
7 
sl
e 
17
 
0.
8 
73
 
78
.9
4 
1 
14
50
 
4.
52
 
0.
66
 
5.
89
 
5.
25
 
D
PG
N
 
3 
1 
63
 
R
ev
at
hi
 
25
 
F 
62
 
16
4 
ht
n,
sl
e,
dr
ug
 
87
 
2.
3 
10
2 
34
.4
4 
3 
14
00
 
4.
42
 
0.
79
 
6.
72
 
6.
7 
M
em
br
an
ou
s 
3 
2 
64
 
A
m
bi
ka
 
15
 
F 
52
 
15
5 
ht
n 
55
 
4.
2 
91
 
17
.2
 
4 
70
0 
5.
6 
1.
02
 
11
.2
 
6.
6 
D
PG
N
 
3 
1 
65
 
N
ar
as
sa
ia
h 
62
 
F 
61
 
16
0 
ht
n,
ns
ai
d 
11
2 
6.
2 
94
 
8.
52
7 
5 
55
0 
4.
5 
1.
46
 
5.
2 
4.
1 
no
t d
on
e 
3 
1 
66
 
A
ad
i 
17
 
F 
43
 
15
3 
ht
n 
63
 
3.
3 
76
 
17
.8
1 
4 
10
50
 
2.
6 
0.
76
 
6.
01
 
4.
8 
R
PG
N
 
3 
1 
67
 
D
ur
ai
 
52
 
M
 
74
 
17
7 
ns
ai
d 
63
 
1.
3 
11
1 
69
.5
7 
2 
13
00
 
6.
63
 
1.
03
 
7.
76
 
9.
44
 
C
G
N
 
3 
1 
68
 
M
ur
ug
es
an
 
44
 
M
 
71
 
17
5 
ns
ai
d,
dr
ug
 
28
 
0.
9 
85
 
10
5.
2 
1 
11
50
 
3.
79
 
1.
25
 
5.
97
 
3.
9 
Ig
A
 
N
ep
hr
op
at
hy
 
3 
1 
69
 
M
un
us
am
y 
33
 
M
 
59
 
16
6 
  
14
 
0.
8 
86
 
10
9.
6 
1 
17
00
 
4.
6 
0.
76
 
4.
25
 
5.
5 
C
G
N
 
3 
1 
70
 
N
at
ar
aj
 
19
 
M
 
57
 
16
4 
  
42
 
1.
4 
82
 
68
.4
2 
2 
18
50
 
3.
7 
0.
84
 
3.
11
 
3.
8 
R
PG
N
 
3 
1 
71
 
Sa
rv
an
an
 
29
 
M
 
63
 
16
2 
ht
n 
24
 
1.
1 
13
6 
88
.3
 
2 
24
00
 
3.
1 
0.
65
 
3.
22
 
4.
32
 
Ig
A
 
N
ep
hr
op
at
hy
 
3 
1 
72
 
V
en
ka
ta
ch
al
am
 
74
 
M
 
76
 
17
1 
ht
n,
hb
v,
ns
ai
d 
67
 
3.
7 
11
4 
18
.8
3 
4 
26
50
 
2.
6 
0.
62
 
4.
89
 
6.
4 
D
PG
N
 
3 
1 
 W
t -
 W
ei
gh
t o
f p
at
ie
nt
 in
 K
g.
; H
t -
 H
ei
gh
t o
f t
he
 p
at
ie
nt
 in
 c
m
s.
;S
. C
r -
 s
er
um
 C
re
at
in
in
e 
; R
B
S 
- R
an
do
m
 B
lo
od
 S
ug
ar
 ; 
eG
FR
 - 
es
tim
at
ed
 G
lo
m
er
ul
ar
 
Fi
lte
ra
tio
n 
R
at
e 
us
in
g 
th
e 
C
oc
kc
ro
ft
-G
au
lt 
eq
ua
tio
n;
C
K
D
 - 
St
ag
e 
of
 C
K
D
 b
as
ed
 o
n 
E
st
im
at
ed
 G
lo
m
er
ul
ar
 F
ilt
er
at
io
n 
R
at
e 
; 2
4 
hr
 V
ol
 - 
th
e 
vo
lu
m
e 
of
 u
ri
ne
 
co
lle
ct
ed
 o
ve
r 2
4 
ho
ur
s 
m
ea
su
re
d 
in
 m
l.;
A
C
R
 - 
ea
rl
y 
m
or
ni
ng
 s
po
t u
ri
ne
 A
lb
um
in
 C
re
at
in
in
e 
R
at
io
;u
r c
r c
on
c 
- m
ea
su
re
d 
ur
in
ar
y 
C
re
at
in
in
e 
C
on
ce
nt
ra
tio
n 
ex
pr
es
se
d 
in
 m
g/
m
l.;
PC
R
 - 
ea
rl
y 
m
or
ni
ng
 s
po
t u
ri
ne
Pr
ot
ei
n 
C
re
at
in
in
e 
R
at
io
; 2
4 
H
rs
 U
 P
r -
 th
e 
24
 h
ou
rs
 u
ri
na
ry
 p
ro
te
in
 e
xc
re
tio
n 
ex
pr
es
se
d 
in
 g
ra
m
s.
 D
ip
st
ic
 - 
re
su
lt 
of
 u
se
 o
f D
ip
st
ic
k 
te
st
 (
Fo
r E
g:
 3
 =
 +
++
 P
ro
te
in
 ),
at
tm
pt
 –
 n
um
be
r o
f a
tte
m
pt
s 
do
ne
 fo
r a
de
qu
at
e 
24
 h
ou
rs
 u
ri
ne
 c
ol
le
ct
io
n;
 F
SG
S 
– 
Fo
ca
l S
eg
m
en
ta
l 
G
lo
m
er
ul
ar
 s
cl
er
os
is
; C
G
N
 –
 c
hr
on
ic
 G
lo
m
er
ul
o 
sc
le
ro
si
s;
 M
PG
N
 –
 M
em
br
an
o-
Pr
ol
if
er
at
iv
e 
G
lo
m
er
ul
o-
N
ep
hr
iti
s 
;D
PG
N
 –
 D
if
fu
se
 P
ro
lif
er
at
iv
e 
G
lo
m
er
ul
o 
N
ep
hr
iti
s 
; m
em
br
an
ou
s 
– 
M
em
br
an
ou
s 
N
ep
hr
op
at
hy
 ;m
ye
lo
m
a 
–R
en
al
 a
ff
ec
tio
n 
du
e 
to
 M
ye
lo
m
a(
 P
la
sm
a 
C
el
l T
um
or
 );
 h
tn
- s
ys
te
m
ic
 H
yp
er
te
ns
io
n 
;h
bv
- 
C
hr
on
ic
 In
fe
ct
io
n 
w
ith
 H
ep
at
iti
s 
B
 V
ir
us
;h
cv
- C
hr
on
ic
 In
fe
ct
in
 w
ith
 H
ep
at
iti
s 
C
 v
ir
us
;d
ru
g-
 u
se
 o
f n
at
iv
e 
m
ed
ic
in
e 
, o
r d
ru
gs
 k
no
w
n 
to
 c
au
se
 re
na
l i
nj
ur
y 
ex
ce
pt
 
fo
r N
SA
ID
 ;n
sa
id
- N
on
 –
 s
te
ro
id
al
 A
nt
i I
nf
la
m
m
at
or
y 
D
ru
g 
us
e 
;s
le
- S
ys
te
m
ic
 L
up
us
 E
ry
th
em
at
os
us
 ; 
hi
v 
– 
In
fe
ct
io
n 
w
ith
 H
IV
 v
ir
us
 ; 
 
   
 
 
